Pearl Laurence H
Section of Structural Biology, Institute of Cancer Research, Chester Beatty Laboratories, London, SW3 6JB, UK.
Curr Opin Genet Dev. 2005 Feb;15(1):55-61. doi: 10.1016/j.gde.2004.12.011.
The Hsp90 molecular chaperone system is involved in the activation of an important set of cell regulatory proteins, including many whose disregulation drives cancer. Recruitment of protein kinases to the Hsp90 system is mediated by the co-chaperone adaptor Cdc37 -- an essential protein whose overexpression is itself, oncogenic. Current structural, biochemical and biological studies of Cdc37 are beginning to unravel the nature of its interactions with Hsp90 and protein kinase clients, and implicate it as a key permissive factor in cell transformation by disregulated protein kinases. The central role of the Hsp90-Cdc37 chaperone complex makes it an important target for future anti-cancer drug development.
热休克蛋白90(Hsp90)分子伴侣系统参与激活一组重要的细胞调节蛋白,其中包括许多因调节失控而引发癌症的蛋白。共伴侣衔接蛋白Cdc37介导蛋白激酶与Hsp90系统的结合,Cdc37是一种必需蛋白,其过表达本身就具有致癌性。目前对Cdc37的结构、生化和生物学研究开始揭示其与Hsp90及蛋白激酶客户之间相互作用的本质,并表明它是蛋白激酶调节失控导致细胞转化的关键许可因子。Hsp90 - Cdc37伴侣复合物的核心作用使其成为未来抗癌药物研发的重要靶点。